Hypolipidaemic agents: current status and recent developments.
D000103:Acetyl-CoA Carboxylase / Q000378:metabolism; D000273:Adipose Tissue / Q000378:metabolism; D000818:Animals; D002994:Clofibrate / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D006903:Hydroxymethylglutaryl CoA Reductases / Q000378:metabolism; D000960:Hypolipidemic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D008053:Lipid Mobilization / Q000187:drug effects; D008099:Liver / Q000187:drug effects / Q000201:enzymology; D008930:Mitochondria, Liver / Q000187:drug effects / Q000378:metabolism; D014176:Protein Biosynthesis / Q000187:drug effects; D051381:Rats; D013329:Structure-Activity Relationship; D013974:Thyroxine / Q000494:pharmacology / Q000627:therapeutic use; D014158:Transcription, Genetic / Q000187:drug effects
D000960:Hypolipidemic Agents; D006903:Hydroxymethylglutaryl CoA Reductases; D000103:Acetyl-CoA Carboxylase; D002994:Clofibrate; D013974:Thyroxine